Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin [Phase 3]
Phase 3 study comparing the efficacy and safety of pitavastatin versus simvastatin in adults with hypercholesterolemia and dyslipidemia; res…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia [Phase 3]
A Phase 3 trial comparing pitavastatin and atorvastatin in patients with type 2 diabetes mellitus and dyslipidemia has completed with result…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia [Phase 3]
Phase 3 follow-on trial comparing pitavastatin and atorvastatin in patients with type 2 diabetes mellitus and dyslipidemia; study completed …
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia [Phase 3]
Long-term extension study results for pitavastatin in patients with primary hypercholesterolemia or combined dyslipidemia (Phase 3) have bee…
-
FDA approval · 2010-01-08FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Pravastatin Sodium (generic pravastatin) under the ANDA, authoriz…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: MK0524B Bioequivalence Study (0524B-070) [Phase 1]
A Phase 1 bioequivalence study (0524B-070) for MK0524B in dyslipidemia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-12-30Clinical Trial Update: Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins [NA]
Clinical trial evaluating whether SMS reminders improve adherence to long-term statin therapy in patients with dyslipidemia. The study statu…
-
CLINICAL_TRIALS trial_result · 2009-12-16Clinical Trial Update: Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels [Phase 3]
A Phase 3 trial comparing the lipid-lowering efficacy of pitavastatin versus atorvastatin in primary hypercholesterolemia and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2009-12-16Clinical Trial Update: Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin [Phase 3]
Phase 3 trial comparing the efficacy and safety of pitavastatin versus simvastatin in patients with hypercholesterolemia and dyslipidemia; r…
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Fenofibrate Bioequivalence Study (0767-031) [Phase 1]
A Phase 1 bioequivalence study of fenofibrate for dyslipidemia has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: MK0524A Bioequivalence Study (0524A-059) [Phase 1]
Phase 1 bioequivalence study of MK0524A (0524A-059) in dyslipidemia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-11-06Clinical Trial Update: A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk [Phase 4]
Phase 4 trial comparing a multi-risk factor strategy to guideline-based approach for achieving blood pressure and lipid goals in high-risk h…
-
CLINICAL_TRIALS trial_result · 2009-10-20Clinical Trial Update: Association of Genes to Resistance to Weight Loss in Obese Patients
A completed clinical trial from Interleukin Genetics investigates how genetic variation may influence resistance to weight loss in obese ind…
-
CLINICAL_TRIALS trial_result · 2009-10-09Clinical Trial Update: Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin [Phase 3]
Phase 3 trial evaluating a Flushing Assessment Tool (FAST) in dyslipidemia patients treated with niacin extended-release plus aspirin; resul…
-
CLINICAL_TRIALS trial_result · 2009-09-14Clinical Trial Update: Omentectomy for the Treatment of Diabetes Mellitus Type 2 [Phase 1]
A Phase 1 trial evaluating omentectomy as a treatment for type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-14Clinical Trial Update: Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia
A completed clinical trial studied the effect of gastric bypass surgery on patients with type 2 diabetes mellitus and/or dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia [Phase 3]
Phase 3 trial evaluating whether acetylsalicylic acid reduces flushing caused by Niaspan in adults with dyslipidemia; the study is completed…
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels [Phase 4]
Phase 4 clinical trial assessing the effect of plant sterols esterified to fish oil fatty acids on plasma lipid levels in dyslipidemia; resu…
-
CLINICAL_TRIALS trial_result · 2009-08-12Clinical Trial Update: The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients. [Phase 3]
Phase 3 study evaluating Dunaliella bardawil extract as a source of 9-cis retinoic acid to modify lipid profiles in fibrate-treated patients…
-
CLINICAL_TRIALS research · 2009-08-07Clinical Trial Update: Reduce Obesity and Diabetes
A clinical trial update about a study aimed at reducing obesity and diabetes, involving Type 2 Diabetes, pediatric obesity, and dyslipidemia…
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: National Survey on Dyslipidemic Patients
AstraZeneca-sponsored clinical trial survey of dyslipidemia patients has completed.
-
FDA approval · 2009-08-03FDA Approved: LIVALO — Original Application (Kowa Pharmaceuticals America, Inc.)
FDA approved LIVALO (pitavastatin calcium) from Kowa Pharmaceuticals America, Inc. as an original NDA (NDA022363) for the treatment of hyper…
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. [Phase 3]
A Phase 3 trial evaluating ABT-335 in combination with three different statins in subjects with mixed dyslipidemia, examining long-term safe…
-
CLINICAL_TRIALS withdrawal · 2009-07-20Clinical Trial Update: Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS) [Phase 3]
Phase 3 VENUS trial of rimonabant in Japanese obese patients with dyslipidemia has been terminated.
-
CLINICAL_TRIALS research · 2009-07-13Clinical Trial Update: Cardioprotective Effects of Green Tea Versus Maté Intake [Phase 3]
This Phase 3 trial evaluates the cardioprotective effects of green tea compared with maté intake in individuals with dyslipidemia, inflammat…